About Ansell (ASX: ANN)
Ansell Limited designs, develops, manufactures, and distributes hand and body protection solutions across the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. The company operates through two segments, Healthcare and Industrial, serving a broad range of end markets from hospitals and surgical centres to chemical plants, mining operations, and food processing facilities.
The Healthcare segment covers surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments for customers including hospitals, dental surgeries, veterinary clinics, laboratories, and life sciences and pharmaceutical companies. The Industrial segment focuses on hand and chemical protective clothing for applications spanning automotive, metal fabrication, construction, oil and gas, utilities, and logistics. Products are sold under a portfolio of brands including ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, TouchNTuff, and VIKING, among others. Formerly known as Pacific Dunlop Limited, the company adopted the Ansell name in 2002 and traces its origins to its founding in 1893. Ansell is headquartered in Richmond, Australia.
MFAM Research
- [BUY] Ansell (ASX ANN) is a Personal Protective Equipment Manufacturer and a Great Pandemic HedgeOctober 28, 2020Today, we’ll look at why we like Ansell shares (ASX ANN A$45.12 ▼ -2.02%). Ansell specialises in manufacturing and distributing personal protective equipment (PPE). we first recommended Ansell back in April during the COVID crash and we take a deeper dive into the stock today. If the world is to learn from its COVID mistakes, […]
A rules-based approach to leveraged ETFs
See how our quantitative strategy works and who it suits.
Explore the strategyBecome an authorised representative
Advise your clients under an established AFSL without building your own. Choose AR or CAR.
Become an AR or CARLatest Announcements
- Ansell (ASX: ANN) – Ansell FY26 Full Year Results PresentationAugust 24, 2026Ansell delivered adjusted earnings per share growth of 18.5% to 148.6 US cents in FY26, the strongest result since FY21, as the company navigated a year marked by US tariff implementation, Middle East supply chain disruptions, and volatile input cost inflation. The result reflected not just top-line growth of 5.0% on an organic constant currency […]
- Ansell (ASX: ANN) – FY26 Full Year Results and BuybackAugust 24, 2026Ansell Limited has delivered adjusted earnings per share of US148.6¢ for the full year ended 30 June 2026, landing in the upper half of the company’s guidance range. This represents growth of 17.8% on an organic constant currency basis from the prior year’s US126.1¢, demonstrating the company’s ability to drive earnings expansion through higher sales […]
- Ansell (ASX: ANN) – Files 2026 Full Year ReportAugust 24, 2026Ansell Limited delivered a substantial turnaround in profitability for FY26, with operating profit after tax doubling to US$208.6 million, representing 105.3% growth on the prior year. This significant earnings expansion comes against a more modest revenue backdrop, with sales reaching US$2,140.2 million, up 6.8% from the previous corresponding period. The divergence between top-line and bottom-line […]
Financial Summary
Price History
Related Stocks
| Same Industry — Healthcare | Same Sub-Industry — Medical Instruments & Supplies |
|---|---|